Gyre Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $19.00 on 11/12/24 and a low of $8.26 for the same time frame on 08/05/24.
52-week price history of GYRE Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Gyre Therapeutics Inc’s current trading price is -54.89% away from its 52-week high, while its distance from the 52-week low is 3.75%. The stock’s price range during the 52-week period has remained between $8.26 and $19.00. In the Healthcare sector, the company’s shares saw a trading volume of around 0.74 million for the day, which was evidently higher than the average daily volume of 91570.0 over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Gyre Therapeutics Inc (GYRE) has experienced a quarterly decline of -12.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 735.50M and boasts a workforce of 4 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.97, with a change in price of -5.58. Similarly, Gyre Therapeutics Inc recorded 98,781 in trading volume during the last 100 days, posting a change of -39.43%.
Examining GYRE’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for GYRE stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.
GYRE Stock Stochastic Average
As of today, Gyre Therapeutics Inc’s raw stochastic average for the last 50 days stands at 1.61%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 1.61%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 44.71% and 56.47%, respectively.
GYRE Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -29.17% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -36.57%. Over the past 30 days, the price of GYRE has leaped by -28.46%. And in the last five days, it has fallen by -24.49%.
